Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 9, Issue 396, Pages eaal3694
Publisher
American Association for the Advancement of Science (AAAS)
Online
2017-09-30
DOI
10.1126/scitranslmed.aal3694
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Non-alcoholic fatty liver disease in 2016
- (2016) S.A. Townsend et al. BRITISH MEDICAL BULLETIN
- Innate Immunity and Inflammation in NAFLD/NASH
- (2016) Marco Arrese et al. DIGESTIVE DISEASES AND SCIENCES
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis
- (2016) Richard L. Gieseck et al. IMMUNITY
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
- (2015) Samar H. Ibrahim et al. DIGESTIVE DISEASES AND SCIENCES
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
- (2015) Sheila Cristina L. Sanches et al. Biomed Research International
- Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities
- (2014) Mina Shaker WORLD JOURNAL OF GASTROENTEROLOGY
- Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis
- (2013) Hiroshi Fujishima et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Prostaglandin D2 receptord-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus
- (2013) S. Zhang et al. DISEASES OF THE ESOPHAGUS
- Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice
- (2013) Ling Yang et al. HEPATOLOGY
- Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages
- (2013) Ari B. Molofsky et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Eosinophils secrete IL-4 to facilitate liver regeneration
- (2013) Y. P. S. Goh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice
- (2012) William R. Proctor et al. HEPATOLOGY
- Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
- (2012) Guiquan Jia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Periostin promotes chronic allergic inflammation in response to Th2 cytokines
- (2012) Miho Masuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling
- (2011) Hariom Yadav et al. Cell Metabolism
- Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
- (2011) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Smad3 Deficiency in Mice Protects Against Insulin Resistance and Obesity Induced by a High-Fat Diet
- (2011) C. K. Tan et al. DIABETES
- Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease
- (2011) A. D. Lake et al. DRUG METABOLISM AND DISPOSITION
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice
- (2011) Andrew M. Miller et al. HEPATOLOGY
- Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps
- (2011) Julie A. Poposki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lebrikizumab Treatment in Adults with Asthma
- (2011) Jonathan Corren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis
- (2011) D. Wu et al. SCIENCE
- TGF-β1 and FAK Regulate Periostin Expression in PDL Fibroblasts
- (2010) W. Wen et al. JOURNAL OF DENTAL RESEARCH
- IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity
- (2010) R. R. Ricardo-Gonzalez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
- (2008) Dennys E. Cintra et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started